Jul 31, 2021 01:27 PM IST
His advice to young leaders: "Focus on relationships and building trust with your customers, your partners and your employees."
- Nov 15, 2019 11:55 AM IST
The apex court earlier asked former Ranbaxy promoters Malvinder Singh and Shivinder Singh to give it a plan as to how they would honour the arbitral award of Rs 3,500 crore granted by a Singapore tribunal against them and in favour of Japanese drug manufacturer Daiichi Sankyo.
- Oct 10, 2019 06:11 PM IST
The EOW of Delhi Police is also on the lookout for former Ranbaxy CEO Malvinder Singh.
- Jun 10, 2019 12:25 PM IST
Like other books on corporate fraud, Bottle of Lies is a cautionary tale about how the relentless quest for high growth and profits at any costs can corrupt organisations in the absence of a strong, ethical core and sustained, rigorous, regulatory oversight.
- Mar 14, 2019 12:58 PM IST
A bench headed by Chief Justice Ranjan Googi asked the Singh brothers, who were present in the court, to consult their financial and legal advisors and give a concrete plan on how they will comply with the tribunal's order.
- Jan 01, 2019 01:57 PM IST
The whistleblower allegations have raised governance concerns at Sun Pharma. Investors are better placed in proactively raising their concerns with the board, to ensure that the new governance structure at Sun Pharma is robust, in their compliance and intent
- Dec 06, 2018 04:34 PM IST
The Delhi High Court has already granted a status quo over sale of assets by RHC Holding.
- Mar 21, 2017 09:34 PM IST
Over the last decade, “data integrity” has turned out to be the most discussed and perhaps the most dreaded word for the Indian pharmaceutical companies.
- Mar 15, 2017 12:54 PM IST
CLSA says Mohali plant clearance is a significant positive development for the company and shows progress on regulatory issues. Clearance makes a large oral solid dosage site available to de-risk existing sites.
- Mar 14, 2017 02:44 PM IST
Sun Pharma said the proposed action will clear path for supply approved products from the Mohali faciity to the US market.
- Mar 14, 2017 02:07 PM IST
The company informed the exchanges that the US Food and Drug Administration was planning to remove the firm from Official Action Initiated (OIA) status.
- Feb 22, 2017 10:42 AM IST
Former CEO of Ranbaxy, Brian Tempest, expects more pricing pressure to come in US under Donald Trump administration.
- Jan 11, 2017 12:57 PM IST
â€œDaiichi Sankyo is reviewing its global R&D system with the aim of decreasing R&D operations costs and redistributing resources to the further development of its R&D pipeline,â€ the company said in a statement.
- Jan 01, 2017 12:00 AM IST
With Nifty a whisker away from its lifetime high and valuation touching 21X FY17P and 18X FY18P earnings, the Street looks cautious. Is it time to take money off the table?
- Dec 21, 2016 06:24 PM IST
For investors, the Sun Pharma stock has long stood for a focus on growth, both through organic and inorganic routes. Is this lack of focus through unrelated investments the reason for its underperformance?
- Nov 21, 2016 08:55 AM IST
Wockhardt, Sun Pharma, Tara, Novartis and other pharma company Perrigo are also in focus on account of reports from the US that there are lawsuits filed by Unions representing the New York Police Department on price collusion of two dermatology products.
- Nov 04, 2016 10:44 AM IST
In an interview to CNBC-TV18, Deven Choksey, MD of KRChoksey Investment Managers Private Limited shared his readings and outlook on specific stocks and sectors.
- Aug 26, 2016 04:12 PM IST
Gaurang Shah of Geojit BNP Paribas is of the view that one may look at Sun Pharmaceutical Industries.
- Jun 07, 2016 08:46 AM IST
The merger between Sun and Ranbaxy achieved closure towards the end of March 2015.
- May 31, 2016 01:25 PM IST
The company also said that the pharma major will continue to build speciality business which could impact short term profitability. It also cautioned that it could lose anywhere between 5-10 percent due to pricing pressure and peer consolidation in the US.
- May 26, 2016 09:54 PM IST
Daiichi Sankyo, Daiichi Sankyo (Thailand) Ltd, Sun Pharmaceutical Industries Ltd, Ranbaxy (Netherlands) BV and Ranbaxy (Thailand) Company Ltd entered into a termination agreement on May 26, 2016.
- May 09, 2016 03:18 PM IST
Joint inspections with eight other regulators carried at six of Ranbaxy‘s laboratories in Himachal Pradesh found discrepancies in testing, stability standards and expiry dates, among other standards.
- May 06, 2016 01:50 PM IST
In a tweet, the watchdog today said it has cleared "PVR's acquisition of DT Cinema's multiplexes/single screen theaters in Delhi NCR and Chandigarh, subject to modification".
- May 05, 2016 08:47 PM IST
Malvinder and Shivinder Singh had sold their stake in Ranbaxy Laboratories to Daiichi way back in 2008, following which Daiichi-led Ranbaxy was forced to pay the US Department of Justice a sum of USD 500 million over non-compliance with US Food and Drug Administration's testing norms.
- Apr 30, 2016 12:02 PM IST
The past few years have been rough of Indian pharma companies, what with the US FDA raking them over the coals over alleged manufacturing lapses and discrepancies.